Platelet-rich Plasma for Low Back Pain
Intradiscal Injection of Platelet-rich Plasma for Discogenic Pain in L-spine
1 other identifier
interventional
30
1 country
1
Brief Summary
This study aims to evaluate the effect of platelet-rich plasma (PRP) on discogenic low back pain by comparing the pre- and post-interventional outcomes in patients receiving intradiscal injection of autologous PRP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 22, 2016
CompletedFirst Submitted
Initial submission to the registry
April 13, 2017
CompletedFirst Posted
Study publicly available on registry
June 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2019
CompletedSeptember 6, 2019
September 1, 2019
2.9 years
April 13, 2017
September 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1-month postoperative function evaluated by Oswestry Disability Index
Function is evaluated using Oswestry Disability Index.
1-month postoperative
Secondary Outcomes (3)
4-month postoperative function evaluated by Oswestry Disability Index
4-month postoperative
1-month postoperative pain evaluated by visual analogue scale
1-month postoperative
4-month postoperative pain evaluated by visual analogue scale
4-month postoperative
Study Arms (1)
PRP group
EXPERIMENTALIntradisc injection of autologous platelet-rich plasma gel
Interventions
Eligibility Criteria
You may qualify if:
- Age between 20 and 60 years
- L-spine disc degeneration diagnosed by MRI
- Low back pain
You may not qualify if:
- Herniated disc
- With prior history of spine surgery
- With current or prior history of cancer
- With current or prior history of hematological disease
- Pregnancy
- Patients who will not cooperate with one-year followup
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pei-Yuan Lee, MDlead
- Aeon Biotechnology Corporationcollaborator
Study Sites (1)
Show Chwan Memorial Hospital
Changhua, Changhua, 500, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pei-Yuan Lee, MD
Show Chwan Memorial Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Superintendent
Study Record Dates
First Submitted
April 13, 2017
First Posted
June 23, 2017
Study Start
April 22, 2016
Primary Completion
March 25, 2019
Study Completion
March 25, 2019
Last Updated
September 6, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share